.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
UBS
McKinsey
Covington
Daiichi Sankyo
Chinese Patent Office
Fuji
Federal Trade Commission
McKesson
QuintilesIMS

Generated: December 12, 2017

DrugPatentWatch Database Preview

ANAPROX Drug Profile

« Back to Dashboard

Which patents cover Anaprox, and what generic alternatives are available?

Anaprox is a drug marketed by Atnahs Pharma Us and is included in one NDA.

The generic ingredient in ANAPROX is naproxen sodium. There are forty-two drug master file entries for this compound. One hundred and fifty-four suppliers are listed for this compound. Additional details are available on the naproxen sodium profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Atnahs Pharma UsANAPROXnaproxen sodiumTABLET;ORAL018164-001Approved Prior to Jan 1, 1982ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Atnahs Pharma UsANAPROX DSnaproxen sodiumTABLET;ORAL018164-003Sep 30, 1987ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ANAPROX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Atnahs Pharma UsANAPROXnaproxen sodiumTABLET;ORAL018164-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Atnahs Pharma UsANAPROXnaproxen sodiumTABLET;ORAL018164-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Atnahs Pharma UsANAPROXnaproxen sodiumTABLET;ORAL018164-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Teva
Express Scripts
Merck
Medtronic
Accenture
McKinsey
Moodys
Chubb
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot